With advances in genetics and genomics driving the paradigm shift towards personalized medicine

With advances in genetics and genomics driving the paradigm shift towards personalized medicine, what are the implications for healthcare delivery, clinical decision-making, and patient outcomes? How can genomic data and precision medicine approaches inform disease risk assessment, pharmacogenomics-guided therapy selection, and targeted interventions, while also addressing concerns related to genetic privacy, equity in access, and the ethical use of genetic information?